| abstract |
The present invention provides a combination for use as a protein kinase B inhibitor, said combination comprising an auxiliary compound and a compound of formula (I) or a salt, solvate, tautomer or N-oxide thereof (formula Wherein R 1 , Q 1 , Q 2 , E, G, T, R 4 , J 1 and J 2 are as defined in the claims), or (II) a compound of formula (I) or Its salts, solvates, tautomers or N-oxides, wherein R 1 , R 2 , R 3 , R 4 , E, A, T, J 1 and J 2 are defined in the claims Are synonymous with) (or consist essentially of). |